Roche Will Miss Goal of Filing RNAi Rx IND This Year, Tekmira Exec Says

As reported by Gene Silencing News in 2009, Roche had been expecting to file the IND on what would be its first RNAi drug sometime this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories